A comprehensive review of clinical and real-world safety data for the four-component serogroup B meningococcal vaccine (4CMenB)

• Principais autores: Gary S. Marshall (Autor), Victoria Abbing-Karahagopian (Autor), Helen S. Marshall (Autor), Silvia Cenci (Autor), James H. Conway (Autor), Emilia Occhipinti (Autor), Rafik Bekkat-Berkani (Autor), Angelika Banzhoff (Autor), Woo-Yun Sohn (Autor)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2023-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction Neisseria meningitidis causes invasive meningococcal disease and, globally, significant morbidity, with serogroup B (MenB) being the most common cause of endemic disease and outbreaks in several regions. Extensive use of the four-component serogroup B meningococcal vaccine (4CMenB; Bexs...